1. Home
  2. PRPO vs SILO Comparison

PRPO vs SILO Comparison

Compare PRPO & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

HOLD

Current Price

$27.95

Market Cap

44.4M

Sector

Industrials

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.40

Market Cap

4.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPO
SILO
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Apparel
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
44.4M
4.6M
IPO Year
2000
2011

Fundamental Metrics

Financial Performance
Metric
PRPO
SILO
Price
$27.95
$0.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.8K
3.1M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
92.15
57.98
EPS
N/A
N/A
Revenue
$24,049,000.00
$72,102.00
Revenue This Year
N/A
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.77
N/A
52 Week Low
$5.10
$0.22
52 Week High
$29.53
$1.18

Technical Indicators

Market Signals
Indicator
PRPO
SILO
Relative Strength Index (RSI) 54.21 53.20
Support Level $22.96 $0.33
Resistance Level $28.76 $0.40
Average True Range (ATR) 1.59 0.05
MACD 0.04 0.01
Stochastic Oscillator 66.48 25.41

Price Performance

Historical Comparison
PRPO
SILO

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: